Assessment of nociception in acrylamide-induced neuropathy in rats.

Bing Ling,Nicolas Authier,David Balayssac,Alain Eschalier,François Coudore
DOI: https://doi.org/10.1016/j.pain.2005.09.021
IF: 7.926
2005-01-01
Pain
Abstract:Acrylamide was intraperitoneally administered to male Sprague-Dawley rats at four different doses (5, 10, 20 and 30mg/kg) three times a week for 5 consecutive weeks. Because of motor dysfunction, the 30mg/kg dose was not used for behavioral pain tests. Clinical status remained good throughout the experiment and no motor deficit was observed at the other doses. We showed that acrylamide administration at low doses and cumulative dose (CD) range of 35–140mg/kg produced mechanical allodynia and rapid, marked heat (42°C) and cold (10°C) allodynia after tail immersion test. Mechanical and thermal hyperalgesia appeared after higher cumulative doses (70–280mg/kg), except for cold (4°C) hyperalgesia (20–80mg/kg). All the modifications persisted throughout all study, except the mechanical hyperalgia. All the cumulative doses tested were lower than those generally reported to induce motor dysfunction (CD>250mg/kg), confirming that CD may be considered to be a suitable index in assessing neurological signs and suggesting that early detection of acrylamide neurotoxicity would be possible using the sensory tests, especially those for detecting allodynia thresholds.
What problem does this paper attempt to address?